PLA2G4E anticorps (C-Term)
Aperçu rapide pour PLA2G4E anticorps (C-Term) (ABIN632624)
Antigène
Voir toutes PLA2G4E AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- PLA2 G2 antibody was raised against the c terminal of PLA2 2
-
Purification
- Affinity purified
-
Immunogène
- PLA2 G2 antibody was raised using the C terminal of PLA2 2 corresponding to a region with amino acids TFFPLINDTFRKYKAPGVERSPEELEQGQVDIYGPKTPYATKELTYTEAT
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PLA2G4E Blocking Peptide, (ABIN5615402), is also available for use as a blocking control in assays to test for specificity of this PLA2G4E antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PLA0 0 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PLA2G4E (Phospholipase A2, Group IVE (PLA2G4E))
-
Autre désignation
- PLA2G4E
-
Sujet
- PLA2G4E is a calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position.
-
Poids moléculaire
- 96 kDa (MW of target protein)
-
Pathways
- Inositol Metabolic Process, VEGF Signaling
Antigène
-